Leukemia Genetics tests in Dubai & UAE

Compare available Leukemia Genetics tests, their listed prices and the information provided for each option. Test selection and preparation should be discussed with your clinician.

Tests in this category

Listed price range

600.00–3,200.00 AED

Clinical preparation

Confirm test-specific instructions with your clinician or laboratory.

Compare available tests

Leukemia Genetics test prices

Showing 1–13 of 13 matching tests.

Leukemia Genetics diagnostic tests, details, and listed prices
Test and description	Specimen	Typical duration	Price	Options
TEST-1872 Acute Leukemia Mini Panel (AML/ETO, INV[16], PML/RARA, BCR/ABL, TEL/AML1, MLL, E2A) Test This test identifies seven specific gene fusions commonly found in acute myeloid and lymphoblastic leukemias.	Bone Marrow Aspirate / Peripheral Blood	5–6 Working Days	1,300.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["AML/ETO fusion gene", "INV[16] fusion gene", "PML/RARA fusion gene", "BCR/ABL fusion gene", "TEL/AML1 fusion gene", "MLL fusion gene", "E2A fusion gene"] Parameters [] Preparation ["Fasting is not required.", "Bring a valid Emirates ID and a doctor’s prescription.", "Sample collection is performed via hospital extraction only."] Indications ["Diagnosis and classification of acute leukemia", "Prognosis assessment", "Guidance for targeted therapy selection", "Monitoring minimal residual disease (in specific contexts)"] Measurement technique Confirm with laboratory Codes LOINC: 95727-6 ICD-10: C92.00, C91.00 Clinical summary This test identifies seven specific gene fusions commonly found in acute myeloid and lymphoblastic leukemias.
TEST-1740 CBFB-MYH11 (Inv(16)) Qualitative Test This test detects the presence or absence of the CBFB-MYH11 fusion transcript, a specific genetic abnormality associated with a favorable prognosis in acute myeloid leukemia.	Peripheral Whole Blood	3–4 business days	600.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["CBFB-MYH11 fusion transcript"] Parameters [] Preparation [] Indications ["Diagnosis of acute myeloid leukemia", "Risk stratification in AML", "Guiding therapeutic decisions in AML"] Measurement technique Confirm with laboratory Codes LOINC: 31626-8 ICD-10: C92.0 Clinical summary This test detects the presence or absence of the CBFB-MYH11 fusion transcript, a specific genetic abnormality associated with a favorable prognosis in acute myeloid leukemia.
TEST-1628 E2A Gene Rearrangement FISH Test for Acute Lymphoblastic Leukemia (ALL) This test detects the t(1;19) translocation involving the E2A (TCF3) gene, a significant genetic marker in B-cell Acute Lymphoblastic Leukemia (B-ALL).	Bone Marrow Aspirate (Preferred) or Peripheral Blood	3–4 Business Days	700.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["E2A (TCF3) gene rearrangements", "t(1;19)(q23;p13.3) translocation", "TCF3-PBX1 fusion oncogene"] Parameters [{"name": "Diagnostic Sensitivity", "reference_range": "99.9%"}] Preparation ["No specific patient preparation required.", "Sample collection must be performed by a healthcare professional in a hospital setting."] Indications ["Diagnosis of Acute Lymphoblastic Leukemia (ALL)", "Risk stratification in B-ALL", "Guiding treatment decisions", "Monitoring for minimal residual disease (MRD)"] Measurement technique Confirm with laboratory Codes LOINC: 94068-6 ICD-10: C91.00, C91.02 Clinical summary This test detects the t(1;19) translocation involving the E2A (TCF3) gene, a significant genetic marker in B-cell Acute Lymphoblastic Leukemia (B-ALL).
TEST-1340 MLL (KMT2A) t(4;11)(q21;q23) Translocation Qualitative Test This test qualitatively detects the presence of the t(4;11)(q21;q23) translocation involving the KMT2A gene, a key marker for high-risk acute lymphoblastic leukemia (ALL).	Bone Marrow Aspirate or Peripheral Blood (EDTA)	3–4 working days (preliminary in 24 h)	600.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Presence of t(4;11)(q21;q23) translocation", "KMT2A-AF4 fusion gene"] Parameters [] Preparation ["No specific patient preparation required"] Indications ["Diagnosis of acute lymphoblastic leukemia (ALL)", "Risk stratification in ALL", "Guiding treatment decisions in ALL"] Measurement technique Confirm with laboratory Codes LOINC: 94415-1 ICD-10: C91.00 Clinical summary This test qualitatively detects the presence of the t(4;11)(q21;q23) translocation involving the KMT2A gene, a key marker for high-risk acute lymphoblastic leukemia (ALL).
TEST-1286 NPM1 & FLT3 Mutation Analysis Test This diagnostic test evaluates for the presence of specific mutations in the NPM1 and FLT3 genes within a patient's leukemic cells.	Bone marrow aspirate or peripheral blood	7–8 working days	1,600.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["NPM1 gene mutations", "FLT3 gene mutations"] Parameters [{"name": "NPM1 Mutation Status", "reference_range": null}, {"name": "FLT3 Mutation Status", "reference_range": null}] Preparation ["No specific preparation needed for bone marrow aspiration", "Doctor may advise fasting if sedation is planned", "Bring a complete list of current medications and physician's referral form"] Indications ["Clinical suspicion of hematologic malignancy", "Risk stratification in acute myeloid leukemia (AML)", "Therapeutic decision-making in AML"] Measurement technique Confirm with laboratory Codes LOINC: 92814-7 ICD-10: C92.0, D46.9 Clinical summary This diagnostic test evaluates for the presence of specific mutations in the NPM1 and FLT3 genes within a patient's leukemic cells.
TEST-2051 PAX5 Germline Mutation Susceptibility Test for Acute Lymphoblastic Leukemia (NGS) This test evaluates the DNA sequence of the PAX5 gene to detect germline mutations associated with an increased risk of developing Acute Lymphoblastic Leukemia (ALL).	Peripheral Whole Blood	21–28 Days (3–4 Weeks)	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["PAX5 gene sequence", "Germline mutations (point mutations, deletions, duplications)"] Parameters [] Preparation ["No specific fasting required", "Inform phlebotomist of any medications"] Indications ["Individuals with a family history of ALL", "Risk assessment for ALL susceptibility"] Measurement technique Confirm with laboratory Codes LOINC: 81262-0 ICD-10: Z15.02 Clinical summary This test evaluates the DNA sequence of the PAX5 gene to detect germline mutations associated with an increased risk of developing Acute Lymphoblastic Leukemia (ALL).
TEST-1232 Pediatric Acute Lymphoblastic Leukemia Genetic Panel (Karyotyping + MLPA + FISH) Test This test evaluates chromosomal abnormalities and gene copy number variations in pediatric acute lymphoblastic leukemia to guide risk stratification and treatment.	Peripheral blood (2 mL in sodium heparin tube) or Bone marrow aspirate (1–2 mL)	7–10 working days	3,200.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Chromosomal abnormalities (karyotype)", "Gene deletions and duplications (MLPA)", "Specific gene translocations (FISH)"] Parameters [{"name": "Karyotyping", "reference_range": "Normal human karyotype (46,XX or 46,XY)"}, {"name": "MLPA", "reference_range": "Normal copy number for targeted genes"}, {"name": "FISH", "reference_range": "Normal signal patterns for targeted probes"}] Preparation ["No fasting required", "No medication interruption required", "Routine hydration and normal meals can continue"] Indications ["Initial diagnosis of suspected or confirmed acute lymphoblastic leukemia in children", "Risk stratification for tailored treatment decisions"] Measurement technique Confirm with laboratory Codes LOINC: 80562-5 ICD-10: C91.0 Clinical summary This test evaluates chromosomal abnormalities and gene copy number variations in pediatric acute lymphoblastic leukemia to guide risk stratification and treatment.
TEST-658 RARA/PML Quantitative Test This test quantitatively measures the PML-RARA fusion transcript in blood or bone marrow to diagnose and monitor acute promyelocytic leukemia (APL).	Bone marrow aspiration or peripheral blood	24–72 hours	1,400.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["PML-RARA fusion transcript levels", "Minimal Residual Disease (MRD)"] Parameters [] Preparation ["Bring complete clinical history", "Provide prior leukemia treatment records"] Indications ["Confirmed or highly suspected acute promyelocytic leukemia (APL)", "Risk stratification in APL", "Monitoring treatment response and MRD in APL"] Measurement technique Confirm with laboratory Codes LOINC: 60420-8 ICD-10: C92.4 Clinical summary This test quantitatively measures the PML-RARA fusion transcript in blood or bone marrow to diagnose and monitor acute promyelocytic leukemia (APL).
TEST-1147 RUNX1::RUNX1T1 (AML1-ETO) t(8;21) Qualitative PCR Test This test detects the specific genetic fusion transcript RUNX1::RUNX1T1, associated with the t(8;21) translocation in acute myeloid leukemia (AML).	Bone marrow aspirate or peripheral blood	3–4 working days	600.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["RUNX1::RUNX1T1 fusion transcript"] Parameters [] Preparation [] Indications ["Diagnosis of AML", "Risk stratification in AML", "Monitoring for minimal residual disease (MRD) in AML"] Measurement technique Confirm with laboratory Codes LOINC: 11156-5 ICD-10: C92.0 Clinical summary This test detects the specific genetic fusion transcript RUNX1::RUNX1T1, associated with the t(8;21) translocation in acute myeloid leukemia (AML).
TEST-1633 t(1;19)(q23;p13) E2A Fusion Qualitative Test This test detects the presence or absence of the t(1;19)(q23;p13) E2A-PBX1 fusion transcript in a patient's sample.	Bone marrow aspirate or peripheral blood	3–4 business days	600.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["t(1;19)(q23;p13) E2A-PBX1 fusion transcript"] Parameters [] Preparation [] Indications ["Diagnosis of B-cell acute lymphoblastic leukemia (B-ALL)", "Risk stratification in B-ALL", "Treatment guidance in B-ALL"] Measurement technique Confirm with laboratory Codes LOINC: 48762-6 ICD-10: C91.00 Clinical summary This test detects the presence or absence of the t(1;19)(q23;p13) E2A-PBX1 fusion transcript in a patient's sample.
TEST-3206 t(11;19)(q23;p13.3) MLL-ENL Fusion Qualitative PCR Test This diagnostic test evaluates for the presence of the specific chromosomal translocation t(11;19)(q23;p13.3) resulting in the MLL-ENL fusion gene in leukemia patients.	Whole Blood (3 mL, EDTA Lavender Top) OR Bone Marrow Aspirate (EDTA tube)	3–4 Working Days (Sample Mon/Thu by 11 AM; Report Wed/Sat)	650.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["MLL-ENL fusion transcript", "Presence of t(11;19)(q23;p13.3) translocation"] Parameters [] Preparation ["No fasting required", "Provide complete clinical history including prior chemotherapy, radiation, stem cell transplant dates, and current medications", "Bone marrow aspirate must be collected by a qualified hematologist in a clinical setting"] Indications ["Diagnosis and classification of acute leukemia (AML, ALL, MLL)", "Prognostic assessment", "Guidance for therapy selection (e.g., menin inhibitors)", "Minimal residual disease (MRD) monitoring"] Measurement technique Confirm with laboratory Codes LOINC: 94055-8 ICD-10: C92.60, C92.62, Z15.09 Clinical summary This diagnostic test evaluates for the presence of the specific chromosomal translocation t(11;19)(q23;p13.3) resulting in the MLL-ENL fusion gene in leukemia patients.
TEST-3211 t(9;11)(p21-22;q23) MLL-AF9 Fusion PCR Qualitative Test This test detects the presence of the MLL-AF9 fusion transcript, a specific genetic marker associated with certain types of acute leukemia.	Bone marrow aspirate	3–4 business days	650.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["MLL-AF9 fusion transcript", "t(9;11)(p21-22;q23) chromosomal translocation"] Parameters [] Preparation ["No fasting required", "Avoid anticoagulants if possible"] Indications ["Diagnosis of AML/ALL", "Risk stratification in AML/ALL", "Minimal residual disease (MRD) monitoring in AML/ALL"] Measurement technique Confirm with laboratory Codes LOINC: 60595-2 ICD-10: C92.0 Clinical summary This test detects the presence of the MLL-AF9 fusion transcript, a specific genetic marker associated with certain types of acute leukemia.
TEST-1081 TEL/AML1 (ALL) Genetics Testing Test This test identifies the ETV6-RUNX1 gene fusion, a common genetic marker associated with a favorable prognosis in pediatric B-cell ALL.	Bone Marrow Aspirate / Peripheral Blood	3–4 working days	700.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["ETV6-RUNX1 gene fusion", "t(12;21)(p13;q22) translocation"] Parameters [] Preparation ["No specific patient preparation required."] Indications ["Risk stratification in pediatric B-cell ALL", "Guiding chemotherapy protocol selection", "Prognostic assessment"] Measurement technique Confirm with laboratory Codes LOINC: 33676-7 ICD-10: C91.0 Clinical summary This test identifies the ETV6-RUNX1 gene fusion, a common genetic marker associated with a favorable prognosis in pediatric B-cell ALL.

Category overview

Leukemia Genetics: overview

Uncovering the exact molecular drivers of a blood cancer is essential for unlocking the most effective, targeted oncology treatments available in modern medicine. Within our elite Hematology and Genetics departments, Leukemia Genetics testing evaluates your blood or bone marrow for acquired DNA and RNA mutations—such as BCR-ABL or FLT3—that fuel abnormal white blood cell growth. By leveraging advanced sequencing and molecular technology, this highly focused profiling helps pinpoint the specific oncogenic markers driving the disease, safely guiding your healthcare provider in selecting advanced precision therapies and monitoring long-term remission. Highly regarded for complex oncological diagnostics among the best diagnostic labs in the UAE, DNA Labs ensures strict patient confidentiality, uncompromising analytical precision, and remarkably fast turnaround times. Take control of your personalized cancer care—schedule your leukemia genetics testing in UAE, coordinate a secure clinical sample collection, or consult our expert hematology-oncology team.

Before booking

Use the test details as a conversation starter

The right diagnostic option depends on your reason for testing and individual circumstances. Check the listed specimen and timing, then confirm any preparation requirements with the ordering clinician or laboratory before collection.